Pediatric Infectious Disease

Register      Login

VOLUME 2 , ISSUE 3 ( July-September, 2020 ) > List of Articles

Original Article

Clinical Experience of Granulocyte Transfusion Therapy in Pediatric Patients for Management of Neutropenia-related Infections in a Tertiary Care Center in India

Sunil Bhat, Sohini Chakraborty, Pooja Mallya, Shobha Badiger, Prathip Kumar

Citation Information : Bhat S, Chakraborty S, Mallya P, Badiger S, Kumar P. Clinical Experience of Granulocyte Transfusion Therapy in Pediatric Patients for Management of Neutropenia-related Infections in a Tertiary Care Center in India. Pediatr Inf Dis 2020; 2 (3):85-88.

DOI: 10.5005/jp-journals-10081-1262

License: CC BY-NC 4.0

Published Online: 28-09-2020

Copyright Statement:  Copyright © 2020; The Author(s).


Introduction: In neutropenic patients bacterial and fungal infections are a major cause of morbidity and mortality, especially in hematological malignancies and post-hematopoietic stem cell transplantation. We present here a single institution experience with the use of granulocyte transfusions in children with severe neutropenic sepsis. Material and methods: This is a retrospective analysis of 48 children who received a total of 120 granulocyte transfusions following mobilization with colony-stimulating growth factor (G-CSF) and dexamethasone. Results: Favorable response was seen in 41.6% of the children without any major adverse effects in donor or recipient. Conclusion and clinical significance: Granulocyte transfusions hence may be a useful adjunct to antimicrobials and growth factors in neutropenic sepsis refractory to conventional antimicrobials.

PDF Share
  1. Raj R, Kamath SR, Ranjit S, et al. Granulocyte Transfusion in children. Indian Pediatr 2009;46(6):516–518.
  2. Uppuluri R, Ramachandrakurup S, Vaidhyanathan L, et al. Changing trends in the use of granulocyte transfusions in neutropenic children with sepsis in India. Indian J Hematol Blood Transfus 2017;33(2): 207–210. DOI: 10.1007/s12288-016-0727-2.
  3. Thacker N, Pereira N, Banavali S, et al. Alarming prevalence of community-acquired multidrug-resistant organisms colonization in children with cancer and implications for therapy: a prospective study. Indian J Cancer 2014;51(4):442–446. DOI: 10.4103/0019-509X.175310.
  4. Herzig RH, Herzig GP, Graw RG Jr, et al. Successful granulocyte transfusion therapy for gram negative septicemia: a prospectively randomized controlled study. N Engl J Med 1977;296(13):701–705. DOI: 10.1056/NEJM197703312961301.
  5. Sachs UJ, Reiter A, Walter T, et al. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections. Transfusion 2006;46(11): 1909–1919. DOI: 10.1111/j.1537-2995.2006.00996.x.
  6. Kikuta A, Ohto H, Nemoto K, et al. Therapeutic transfusions of granulocytes collected by simple bag method for children with cancer and neutropenic infections: results of a single-centre pilot study. Vox Sang 2006;91(1):70–77. DOI: 10.1111/j.1423-0410.2006.00776.x.
  7. Bishton M, Chopra R. The role of granulocyte transfusions in neutropenic patients. Br J Haematol 2004;127(5):501–508. DOI: 10.1111/j.1365-2141.2004.05221.x.
  8. Lee J-J, Chung I-J, Park M-R, et al. Clinical efficacy of granulocyte transfusion therapy in patients with neutropenia related infections. Leukemia 2001;15(2):203–207. DOI: 10.1038/sj.leu.2402007.
  9. Drewniak A, Tool AT, Geissler J, et al. Toll-like receptor-induced reactivity and strongly potentiated IL-8 production in granulocytes mobilized for transfusion purposes. Blood 2010;115(22):4588–4596. DOI: 10.1182/blood-2009-11-253245.
  10. Strauss RG. Therapeutic granulocyte transfusions in 1993. Blood 1993;81(7):1675–1678. DOI: 10.1182/blood.V81.7.1675.1675.
  11. Klein HG, Strauss RG, Schiffer CA. Granulocyte transfusion therapy. Semin Hematol 1996;33(4):359–368.
  12. Price TH, Boeckh M, Harrison RW, et al. Efficacy of transfusion with granulocytes from G-CSF/dexamethasone–treated donors in neutropenic patients with infection. Blood 2015;126(18):2153–2161. DOI: 10.1182/blood-2015-05-645986.
  13. Nikolajeva O, Mijovic A, Hess D, et al. Single-donor granulocyte transfusions for improving the outcome of high-risk pediatric patients with known bacterial and fungal infections undergoing stem cell transplantation: a 10-year single-center experience. Bone Marrow Transplant 2015;50(6):846–849. DOI: 10.1038/bmt.2015.53.
  14. Garg A, Gupta A, Mishra A, et al. Role of granulocyte transfusions in combating life-threatening infections in patients with severe neutropenia: experience from a tertiary care centre in North India. PLoS ONE 2018;13(12):e0209832. DOI: 10.1371/journal.pone. 0209832.
  15. Grigull L, Pulver N, Goudeva L, et al. G-CSF mobilized granulocyte transfusions in 32 paediatric patients with neutropenic sepsis. Support Care Cancer 2006;14(9):910–916. DOI: 10.1007/s00520-006-0041-x.
  16. Seidel MG, Minkov M, Witt V, et al. Granulocyte transfusions in children and young adults: does the dose matter? J Pediatr Hematol Oncol 2009;31(3):166–172. DOI: 10.1097/MPH.0b013e318196a6f9.
  17. Atay D, Ozturk G, Akcay A, et al. Effect and safety of granulocyte transfusions in pediatricpatients with febrile neutropenia or defective granulocyte functions. J Pediatr Hematol Oncol 2011;33(6): e220–e225. DOI: 10.1097/MPH.0b013e31821ffdf1.
  18. Zhou B, Song T, Feng Y, et al. Clinical outcome of granulocyte transfusion therapy for the treatment of refractory infection in neutropenic patients with hematological diseases. Ann Hematol 2018;97(11):2061–2070. DOI: 10.1007/s00277-018-3432-4.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.